Shot to the Heart: Moderna Launches Development of mRNA Injection for Heart Attacks
By The Geller Report
You’d have to be mad or suicidal to take a controversial RNA vaccine to correct the crippling side effects of its predecessor RNA ‘vaccine’.
Moderna begins trialing mRNA shot that is injected directly into the HEART to treat heart attack patients
- The shot encodes for relaxin, a hormone which is known to improve blood flow
- Patients have received the injection in a phase one trial looking at dosage levels
- Moderna CEO Stéphane Bancel told Sky News: ‘It’s like science fiction medicine’
By CAITLIN TILLEY, HEALTH REPORTER FOR DAILYMAIL.COM
Moderna is developing an mRNA shot that is injected directly into the hearts of heart attack and heart failure patients.
The ‘vaccine’ uses the same technology as the company’s flagship Covid jab and is designed for people weeks or months after a heart attack to help them recover.
It works by instructing human heart cells to generate a hormone that is known to improve blood flow, helping restore damaged heart muscles.
During a heart attack, muscle cells can start to die and cannot be re-generated. Roughly one in five people who have had a heart attack will be readmitted to the hospital for a second one within five years.
AUTHOR
Pamela Geller
RELATED VIDEO: Judgment Day for Pfizer
EDITORS NOTE: This Geller Report is republished with permission. ©All rights reserved.
This article is courtesy of DrRichSwier.com, an online community of citizen journalists, academics, subject matter experts, and activists to express the principles of limited government and personal liberty to the public, to policy makers, and to political activists. Please visit DrRichSwier.com for more great content.
